Previous 10 | Next 10 |
Summary The management team at General Electric filed some valuable information regarding the upcoming spinoff of its healthcare operations. This new entity, GE HealthCare, is worth a significant amount of money, likely more than General Electric as a whole right now. This pre...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the global markets seeming poised to suffer a significant downturn, investors should prepare for this possibility by targeting cheap value stocks to buy. According to Investopedia.com , value-based investmen...
Summary Sartorius stock has corrected by 55% over the last 12 months, visibly underperforming its peers and the pharmaceutical companies. Despite this, we rate the shares as neutral and stay on the sidelines until order visibility improves. We believe that the business will co...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Earlier this week, Matthew Tuttle’s Tuttle Management filed to create two new exchange-traded funds (ETFs) to track the activity of CNBC’s Mad Money host Jim Cramer. The first, called the Inverse Cr...
Summary Danaher's well-oiled M&A machine runs acquisitions through its signature kaizen-based system, delivering improvements that churn out model returns for shareholders. The Danaher Business System has worked a treat on dozens of deals. Sustaining or replicating a succe...
Danaher Releases 2022 Sustainability Report and Announces New Greenhouse Gas Emissions Reduction Target PR Newswire WASHINGTON , Oct. 5, 2022 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company"), the global science and technology innovator...
Summary Turbulent markets confirm my focus on the dividend growth segment. During September, I made 12 trades; 12 purchases and 0 sales. My projected dividend income is up 13.9% on a year-over-year basis. To quote one of my favorite writers here at Seeking Alpha ...
Summary I'm focused on high-quality companies with growing free cash flows per share. I group my portfolio into 4 buckets: Great capital allocations, Tech Leaders, (unprofitable) High-growth and short-term trades. I want to own companies with great management so that I can sle...
Summary I'm focused on high-quality dividend growth companies. I group my portfolio into 5 buckets: Core Dividend Growth, High Dividend Growth, High Yield, Non-Dividend Payers, and Other Bets. I have a strong focus on filling my portfolio with a large quantity of high-quality ...
Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...